Article

Functional drug screening of tumor organoids on an Active-Matrix Digital Microfluidic Chip for cancer precision medicine

2025-10-20

Abstract excerpt

<title>Abstract</title> <p>Cancer is a leading cause of morbidity and mortality worldwide, characterized by substantial inter-patient and intra-tumor heterogeneity that complicates treatment efficacy. While genomic profiling has advanced precision oncology, the prevalence of tumors lacking targetable mutations highlights the need for complementary functional assays. Here, we present a drug sensitivity testing pla...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9d9c4ce5-8daa-5ede-8ec4-7ad46b489a83
DOI: 10.21203/rs.3.rs-7772352/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Functional drug screening of tumor organoids on an Active-Matrix Digital Microfluidic Chip for cancer precision medicineDOI 10.21203/rs.3.rs-7772352/v1Read

A microfluidic platform for functional assays on tumour biopsy-derived spheroids for precision medicineSemantic proximity Read

Rapid Microfluidic Formation of Uniform Patient-Derived Breast Tumor SpheroidsSemantic proximity Read

Precision Oncology at a Crossroads: How Organoid Platforms Are Reshaping the FieldSemantic proximity Read

Simple droplet microfluidics platform for drug screening on cancer spheroidsSemantic proximity Read

A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironmentsSemantic proximity Read

A dual-functional microfluidic chip for guiding personalized lung cancer medicine: combining EGFR mutation detection and organoid-based drug response test.Semantic proximity Read

Patient-derived esophageal adenocarcinoma organ chip: a physiologically relevant platform for functional precision oncologySemantic proximity Read

Formulation and Characterization of Primary Tissue-Derived Microfluidic Droplet-Engineered OrganoidsSemantic proximity Read

Microfluidic Platform for Drug Response Profiling in NSCLC Patient-Derived OrganoidsSemantic proximity Read

Phenotypic drug profiling in droplet microfluidics for better targeting of drug-resistant tumors.Semantic proximity Read

The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid TumorsSemantic proximity Read

The application of organoids in treatment decision-making for digestive system cancers: progress and challengesSemantic proximity Read